PI Industries Limited has acquired a 100% stake in Italy-based Archimica S.p.A. for USD 38 million, marking a strategic expansion into the pharmaceutical sector.

Information on the Target

PI Health Sciences Limited (PIHS), a wholly-owned subsidiary of PI Industries Limited, has successfully acquired a 100% stake in Archimica S.p.A. for USD 38 million. Established in 1947, PI Industries is a prominent player in India's agri-sciences sector and is recognized for its outstanding manufacturing, quality, and environmental health and safety (EHS) practices. With a focus on expanding its portfolio, PI Industries aims to leverage this acquisition to enhance its pharmaceutical capabilities as part of its diversification strategy.

Archimica S.p.A. is a respected contract development and manufacturing organization (CDMO) based in Italy, specializing in the production of small molecule active pharmaceutical ingredients (APIs). The company caters to a diverse clientele of more than 60 customers across over 30 countries, possessing 24 US Drug Master Files (DMFs) and a good manufacturing practices (GMP) certified facility near Milan, which produces APIs and intermediates across various therapeutic classes, including oncology and anti-inflammatory medications.

Industry Overview in Italy

The pharmaceutical industry in Italy is renowned for its innovation and robust regulatory framework, making it one of the leading markets for pharmaceutical manufacturing in Europe. Known for its substantial research and development investment, t